Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer
This open-label, nonrandomized, phase 1 study assesses the safety of pembrolizumab in patients with HIV and advanced cancer.
This open-label, nonrandomized, phase 1 study assesses the safety of pembrolizumab in patients with HIV and advanced cancer.
The SECA randomized clinical trial assesses the risk of recurrence of chronic subdural hematoma (cSDH) and cardiovascular events in patients undergoing surgical treatment for cSDH…
This secondary analysis of the MR CLEAN-LATE randomized clinical trial studies the interaction between computed tomography perfusion imaging parameters and endovascular treatment with functional outcomes…
This secondary analysis of a randomized clinical trial describes the use of emergency care after self-administration of etripamil by patients experiencing paroxysmal supraventricular tachycardia episodes…
This Viewpoint discusses recent actions by Secretary of Health and Human Services Robert F. Kennedy Jr to rescind the recommendation for COVID-19 vaccines for healthy…
This case-control study investigates if a regional homogeneity–magnetic resonance imaging cortical deficit pattern provides a more robust biomarker for major depressive disorder (MDD) than its…
This systematic review and meta-analysis analyzes the performance of existing risk prediction models for sentinel lymph node biopsy positivity for patients with melanoma.
This survey study estimates the association of states newly implementing continuous Medicaid eligibility under the Families First Coronavirus Response Act with children’s health care access,…
This Viewpoint discusses how sugar-sweetened beverage taxes in small US cities have provided an example for how to enact such policy changes elsewhere, which could…
This Medical News article discusses how the first FDA-cleared blood test for Alzheimer biomarkers should and shouldn’t be used.
This study compares long-term postoperative outcomes by surgeon gender and patient-surgeon gender concordance.